489 related articles for article (PubMed ID: 19931581)
1. Nanotechnology solutions for mucosal immunization.
Chadwick S; Kriegel C; Amiji M
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):394-407. PubMed ID: 19931581
[TBL] [Abstract][Full Text] [Related]
2. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
3. Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
Mann JF; Acevedo R; Campo JD; Pérez O; Ferro VA
Expert Rev Vaccines; 2009 Jan; 8(1):103-12. PubMed ID: 19093777
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Implication of nanoparticles/microparticles in mucosal vaccine delivery.
Vyas SP; Gupta PN
Expert Rev Vaccines; 2007 Jun; 6(3):401-18. PubMed ID: 17542755
[TBL] [Abstract][Full Text] [Related]
6. New insights in mucosal vaccine development.
Pavot V; Rochereau N; Genin C; Verrier B; Paul S
Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
[TBL] [Abstract][Full Text] [Related]
7. Jump-starting the immune system: prime-boosting comes of age.
Woodland DL
Trends Immunol; 2004 Feb; 25(2):98-104. PubMed ID: 15102369
[TBL] [Abstract][Full Text] [Related]
8. Strategies for optimizing targeting and delivery of mucosal HIV vaccines.
Ahlers JD; Belyakov IM
Eur J Immunol; 2009 Oct; 39(10):2657-69. PubMed ID: 19609978
[TBL] [Abstract][Full Text] [Related]
9. Polymer nanotechnology based approaches in mucosal vaccine delivery: challenges and opportunities.
Sharma R; Agrawal U; Mody N; Vyas SP
Biotechnol Adv; 2015; 33(1):64-79. PubMed ID: 25499178
[TBL] [Abstract][Full Text] [Related]
10. [Oral vaccination and vaccine-entrapped microparticle delivery system].
Li FQ; Fei YB; Su H; Hu JH
Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821
[TBL] [Abstract][Full Text] [Related]
11. Novel approaches to pediatric vaccine delivery.
O'Hagan DT; Rappuoli R
Adv Drug Deliv Rev; 2006 Apr; 58(1):29-51. PubMed ID: 16480788
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
Gupta RK; Chang AC; Siber GR
Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immunization using recombinant plant-based oral vaccines.
Streatfield SJ
Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
[TBL] [Abstract][Full Text] [Related]
14. [New routes of administration: epidermal, transcutaneous mucosal ways of vaccination].
Denis F; Alain S; Ploy MC
Med Sci (Paris); 2007 Apr; 23(4):379-85. PubMed ID: 17433227
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary vaccine delivery.
Lu D; Hickey AJ
Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
[TBL] [Abstract][Full Text] [Related]
16. Delivery strategies to enhance oral vaccination against enteric infections.
Davitt CJ; Lavelle EC
Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
[TBL] [Abstract][Full Text] [Related]
17. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria.
van Roosmalen ML; Kanninga R; El Khattabi M; Neef J; Audouy S; Bosma T; Kuipers A; Post E; Steen A; Kok J; Buist G; Kuipers OP; Robillard G; Leenhouts K
Methods; 2006 Feb; 38(2):144-9. PubMed ID: 16414272
[TBL] [Abstract][Full Text] [Related]
18. Bioadhesive delivery systems for mucosal vaccine delivery.
Baudner BC; O'Hagan DT
J Drug Target; 2010 Dec; 18(10):752-70. PubMed ID: 21039314
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles for nasal vaccination.
Csaba N; Garcia-Fuentes M; Alonso MJ
Adv Drug Deliv Rev; 2009 Feb; 61(2):140-57. PubMed ID: 19121350
[TBL] [Abstract][Full Text] [Related]
20. Oral vaccines: new needs, new possibilities.
Aziz MA; Midha S; Waheed SM; Bhatnagar R
Bioessays; 2007 Jun; 29(6):591-604. PubMed ID: 17508389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
